Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2001

View Archived Issues

Scios completes preliminary clinical trial of SCIO-469, its p38 kinase inhibitor

Xenogen and Pfizer establish genetic modification collaboration

MacroChem begins open-label continuation phase III study of Topiglan

Cypress Bioscience and Fresenius restructure Prosorba agreement

Clinical evaluation of Envision TD for DME and posterior uveitis continues

AstraZeneca discontinues development of Zendra

In vivo evidence for alpha1A-adrenoceptor and prostate selectivity of KMD-3213

Chronic treatment with ETA antagonist markedly reduces morbidity and mortality in rat model

NDA for abarelix depot officially filed by FDA; drug assigned priority review status

FDA accepts Amylin's Symlin NDA for review

GenVec provides update on collaborative efforts with Warner-Lambert (Pfizer)

Actos may now be prescribed in U.K. for the management of type 2 diabetes

Dyax's EPI-HNE-4 well tolerated in phase Ib; Debiopharm gains commercialization rights

Actiq introduced in U.K. for patients with breakthrough pain

Safety issue restricts Pfizer capravirine trials

Studies explore mechanism of glucose-dependent insulinotropic effects of JTT-608

Isotechnika's ISAtx-247 to be developed for third indication: psoriasis

New company formed by Inex to develop gene delivery technology

Pfizer extends asthma/allergy drug discovery alliance with Rigel

New Isis antisense compounds modulate hnRNP A1 expression

Tricyclic analgesics and their use in the treatment of pain claimed in recent patent

FR-167653 used to determine role of p38 kinase in H. pylori gastritis

Bone-stimulating factors under evaluation at Osteopharm

Neurim team discovers new melatonin-related compounds with unique profile

Antiviral and antitumor thymine derivatives described in recent patent

Canadian company describes new hexapeptides acting as CCR3 receptor antagonists

DuPont's newest compounds for HIV infection

Apoptosis inducers emerge from R&D at Nippon Kayaku

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...